Therapy of Chronic Myeloid Leukemia: Twilight of the Imatinib Era?

Chronic myeloid leukemia (CML) results from the clonal expansion of pluripotent hematopoietic stem cells containing the active BCR/ABL fusion gene produced by a reciprocal translocation of the ABL1 gene to the BCR gene. The BCR/ABL protein displays a constitutive tyrosine kinase activity and confers...

Descripción completa

Detalles Bibliográficos
Autores principales: Trela, Ewelina, Glowacki, Sylwester, Błasiak, Janusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3929284/
https://www.ncbi.nlm.nih.gov/pubmed/24634785
http://dx.doi.org/10.1155/2014/596483

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3929284/
https://www.ncbi.nlm.nih.gov/pubmed/24634785
http://dx.doi.org/10.1155/2014/596483

Ejemplares similares